--- title: "Dow Extends Record Run With Over 400-Point Pop" type: "News" locale: "en" url: "https://longbridge.com/en/news/294992466.md" description: "The Dow Jones surged over 400 points to new record highs, driven by strong corporate earnings from companies like Disney and Eli Lilly. While the S&P 500 also hit a peak, the Nasdaq declined. Nvidia gained attention due to SpaceX's exclusive processor deal. Individual stocks saw significant moves: Materion soared on earnings beats, Zeta Global attracted heavy call option trading, and DaVita plummeted nearly 20% amid a continued pullback." datetime: "2026-08-05T16:21:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294992466.md) - [en](https://longbridge.com/en/news/294992466.md) - [zh-HK](https://longbridge.com/zh-HK/news/294992466.md) generator: "portal-rs" --- # Dow Extends Record Run With Over 400-Point Pop The Dow Jones Industrial Average (DJI) is up 440 points at midday, trading at more record highs. The S&P 500 Index (SPX) and Nasdaq Composite Index (IXIC) have turned lower, though not before the SPX notched a fresh record peak as well. Nvidia (NVDA) is in focus after Elon Musk said SpaceX (SPCX) will only use Nvidia processors to build its AI computing infrastructure. Investors are continuing to cheer upbeat corporate earnings, with Walt Disney (DIS) and Eli Lilly (LLY) among today’s standout gainers, while optimism surrounding a potential U.S.-Iran agreement to **reopen the Strait of Hormuz** is helping keep oil prices in check. *Continue reading for more on today's market, including:* - **Shopify stock** soars as earnings impress. - **Pharma giant** posts beat-and-raise on GLP-1 demand. - Plus, bulls target ZETA; MTRN's best day ever; and DVA's plummet from highs. Options traders are loading up on **Zeta Global Holdings Corp (NYSE:ZETA)**. More than 99,000 calls have already changed hands, which is 14 times ZETA's average daily pace. The most popular option by far is the weekly 8/7 27-strike call, with new positions opening there too. The stock was last seen up 13.5% at $27.55. Shares of **Materion Corporation (NYSE:MTRN)** are surging 26.2% to trade at $287.00 after the company reported better-than-expected quarterly earnings and revenue. Adjusted earnings per share came out to $1.90 on $613.91 million in revenue. The stock is on track to mark its best daily percentage gain ever and should these gains hold, MTRN could nab its fifth straight daily win. One of the worst performers on the New York Stock Exchange (NYSE) today is **Davita (NYSE:DVA)**, last spotted down 19.3% to trade at $184.36. The shares are continuing their pullback from their August 3 record-high of $247.13 and have fallen to early-May lows, an area that also coincides with the 120-day moving average. DVA remains up 63% year-to-date, however. ### Related Stocks - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [DVA.US](https://longbridge.com/en/quote/DVA.US.md) - [MTRN.US](https://longbridge.com/en/quote/MTRN.US.md) - [ZETA.US](https://longbridge.com/en/quote/ZETA.US.md) - [DIS.US](https://longbridge.com/en/quote/DIS.US.md) - [VOO.US](https://longbridge.com/en/quote/VOO.US.md) - [DIA.US](https://longbridge.com/en/quote/DIA.US.md) - [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md) - [SPY.US](https://longbridge.com/en/quote/SPY.US.md) - [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md) - [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md) - [IVV.US](https://longbridge.com/en/quote/IVV.US.md) - [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [DISO.US](https://longbridge.com/en/quote/DISO.US.md) - [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [SPLG.US](https://longbridge.com/en/quote/SPLG.US.md) - [SPXL.US](https://longbridge.com/en/quote/SPXL.US.md) - [UPRO.US](https://longbridge.com/en/quote/UPRO.US.md) - [SSO.US](https://longbridge.com/en/quote/SSO.US.md) - [SH.US](https://longbridge.com/en/quote/SH.US.md) - [SPXS.US](https://longbridge.com/en/quote/SPXS.US.md) - [SPXU.US](https://longbridge.com/en/quote/SPXU.US.md) - [SDS.US](https://longbridge.com/en/quote/SDS.US.md) - [SPYI.US](https://longbridge.com/en/quote/SPYI.US.md) - [JEPI.US](https://longbridge.com/en/quote/JEPI.US.md) - [XYLD.US](https://longbridge.com/en/quote/XYLD.US.md) - [ZETX.US](https://longbridge.com/en/quote/ZETX.US.md) - [ONEQ.US](https://longbridge.com/en/quote/ONEQ.US.md) - [QQQ.US](https://longbridge.com/en/quote/QQQ.US.md) - [QQQM.US](https://longbridge.com/en/quote/QQQM.US.md) - [QQEW.US](https://longbridge.com/en/quote/QQEW.US.md) - [QQQE.US](https://longbridge.com/en/quote/QQQE.US.md) - [TQQQ.US](https://longbridge.com/en/quote/TQQQ.US.md) - [QLD.US](https://longbridge.com/en/quote/QLD.US.md) - [PSQ.US](https://longbridge.com/en/quote/PSQ.US.md) - [SQQQ.US](https://longbridge.com/en/quote/SQQQ.US.md) - [QID.US](https://longbridge.com/en/quote/QID.US.md) - [DDM.US](https://longbridge.com/en/quote/DDM.US.md) - [UDOW.US](https://longbridge.com/en/quote/UDOW.US.md) - [DOG.US](https://longbridge.com/en/quote/DOG.US.md) - [SDOW.US](https://longbridge.com/en/quote/SDOW.US.md) - [DXD.US](https://longbridge.com/en/quote/DXD.US.md) - [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md) - [SHOP.US](https://longbridge.com/en/quote/SHOP.US.md) - [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md) ## Related News & Research - [Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’](https://longbridge.com/en/news/295770785.md) - [Why Is Omniab Stock Rallying After Eli Lilly Deal?](https://longbridge.com/en/news/296113651.md) - [How Eli Lilly’s Global Vault CRM Rollout At Veeva Systems (VEEV) Has Changed Its Investment Story](https://longbridge.com/en/news/296430987.md) - [Eli Lilly Is Building a Weight Loss Drug for Every Kind of Patient](https://longbridge.com/en/news/296005917.md) - [Elyxium Wealth LLC Has $7.30 Million Position in Eli Lilly and Company $LLY](https://longbridge.com/en/news/296017075.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**